pharmaceutical investing Ritter Pharmaceuticals Completes Dosing of Last Patient in Pivotal 557-Subject Phase 3 Clinical Trial
pharmaceutical investing Ritter Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance
Harvest Gold Identifies 15 Primary And 10 Secondary Targets For Its Diamond Drill Program At Its Mosseau Project In Quebec
HyProMag USA Receives "Make More in America" Domestic Finance Letter of Interest for up to US$92 Million From US EXIM Bank
Aston Bay and American West Metals Announce Drilling Preparations Underway at the Storm Project, Nunavut, Canada